Read the Pharma Pop the Right Way
Pharma spiked on headlines — but proof comes at the close. Use shares or small call spreads, wait for reclaim of key lines, and keep size modest while shutdown noise swirls.
Read MorePharma spiked on headlines — but proof comes at the close. Use shares or small call spreads, wait for reclaim of key lines, and keep size modest while shutdown noise swirls.
Read MoreDC drama? Geof Smith tells us to keep it simple with a starter hedge position in gold — size small, add only if price confirms, and let the daily close do the talking.
Read MoreRefinery shutdowns tighten supply. We outline a tiny, defined-risk way to lean into a survivor—without chasing or betting the farm.
Read MoreChart reason meets options gravity: IBM’s gap-fill toward 270–281 lines up with heavy dealer risk near 275/280. A small Oct 17 call debit spread keeps risk capped while the thesis plays out.
Read MoreGold’s pullback can be constructive; silver’s doing double duty (precious + industrial). Geof Smith’s plan: patient entries and longer-dated credit spreads so time decay works for you — not against you.
Read More